|Articles|October 26, 2001

Vanguard Medical Concepts Inc. Teams with RoundTable Healthcare Partners

LAKELAND, Fl-Vanguard medical Concepts, Inc. has announced that it has received a multimillion-dollar investment fro RoundTable Healthcare Partners-a private equity buyout firm focused on companies in healthcare.

RoundTable will provide industry relationships and resources to accelerate Vanguard's research and development program and other expansion plans.

President and CEO of Vanguard Charles Masek says the business agreement will help his company continue leading the reprocessing industry.

"This partnership presents very exciting opportunities for Vanguard. RoundTable will bring additional leadership ad industry relationships to the reprocessing industry. Ultimately, this association will allow Vanguard to serve the patient at the highest level by providing the resources in research, product development, services, and marketing needed to build on our position as a world-class medical device reprocessor," he said.

The arrangement comes at an important time for the healthcare industry. With new regulations from the US Food and Drug Administration (FDA) concerning medical device reprocessing, hospitals are finding it difficult to find the resources they need to meet the heightened guidelines.

Additionally, Vanguard has signed non-binding letters of intent with both Allegiance Healthcare Corp., and Owens and Minor Inc.,--two of the largest medical and surgical suppliers nationally.

For more information about the partnership, log onto: www.safe-reuse.com


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.